Antiviral drugs for treatment of Arenavirus infection
US9096597B2 · kind B2 · utility
0Cited by
10References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2014 |
| Grant date | Aug 4, 2015 |
| Priority date | — |
| Expiry date | May 7, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D249/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds, methods and pharmaceutical compositions for treating viral infections, by administering certain compounds in therapeutically effective amounts are disclosed. Methods for preparing the compounds and methods of using the compounds and pharmaceutical compositions thereof are also disclosed. In particular, the treatment and prophylaxis of viral infections such as caused by the Arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian hemorrhagic fever, and Venezuelan hemorrhagic fever.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.